v3.22.1
Condensed Statements of Operations (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Income Statement [Abstract]    
Revenues
Operating expenses:    
Research and development 1,506,308 2,654,772
General and administrative 1,744,918 1,358,679
Total operating expenses 3,251,226 4,013,451
Operating loss (3,251,226) (4,013,451)
Other income (expense):    
Interest income 3,173
Interest expense (1,824) (14,560)
Amortization of debt discount and offering costs (8,723) (13,506)
Total other expense (10,547) (24,893)
Net loss $ (3,261,773) $ (4,038,344)
Basic and diluted net loss per share (in Dollars per share) $ (0.04) $ (0.07)
Weighted average common shares outstanding - basic and diluted (in Shares) 86,726,347 61,560,279

Source